If the FDA authorizes it, the additional shot would go to people who are among those with the highest risk of serious illness.
Pfizer and BioNTech are expected to seek U.S. authorization this week for a second Covid-19 vaccine booster for people 65 and older, according to a person familiar with the plans.
More than 66 percent of Americans ages 65 and older who are eligible for a booster have received one, according to data from theIf the additional Pfizer booster is authorized, it's unclear if every eligible person who wants a second booster will be able to get one — the U.S. government currently
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer and BioNTech plan to seek authorization for second COVID booster for people 65 and upNEW: Pfizer and its partner BioNTech plan to seek emergency authorization for a second COVID booster shot for people 65 and older, Axios has confirmed.
続きを読む »
Pfizer to reportedly seek authorization for 2nd COVID-19 booster for older adultsPfizer will seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older, multiple media outlets are reporting.
続きを読む »
Pfizer-BioNTech will seek authorization for second COVID booster for older adultsPfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.
続きを読む »
Pfizer CEO says fourth COVID-19 shot ‘necessary’ due to waning immunityMost people will need to get fourth COVID-19 vaccine dose to be protected from the virus, Pfizer CEO Albert Bourla said on “Face The Nation” on Sunday.
続きを読む »
Pfizer: 4th COVID-19 vaccine dose will be needed“Right now, the way that we have seen, it is necessary, a fourth booster right now,” Pfizer’s CEO Albert Bourla said. FOX13
続きを読む »